Kumquat Biosciences

Kumquat Biosciences

Innovative oncology therapies translating breakthrough science into life-changing cancer treatments. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
$280—420m (Dealroom.co estimates Jul 2021.)
San Diego California (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
*
N/A

$55.9m

Growth Equity VC
N/A

$50.0m

Late VC

$70.0m

Late VC
Total Funding$176m

Recent News about Kumquat Biosciences

Edit
More about Kumquat Biosciencesinfo icon
Edit

Kumquat Biosciences is a biotechnology company dedicated to developing innovative therapies aimed at providing sustainable and life-changing benefits to cancer patients. The company focuses on translating breakthrough scientific discoveries into first-in-class therapeutics. Kumquat Biosciences operates in the oncology market, targeting cancer treatment and care. The business model revolves around drug discovery and development, leveraging the expertise of an accomplished team and distinguished scientific founders with a proven track record in oncology. Revenue is generated through the development and commercialization of proprietary cancer therapies, as well as potential partnerships and collaborations with other pharmaceutical companies. Kumquat Biosciences serves patients, healthcare providers, and the broader medical community by offering advanced treatment options that address unmet medical needs in oncology.

Keywords: oncology, cancer treatment, drug discovery, therapeutics, biotechnology, innovative therapies, breakthrough science, healthcare, pharmaceutical, oncology market.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.